Background To mitigate the effects of COVID-19, a vaccine is urgently needed. BBV152 is a
whole-virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …

Background BBV152 is a whole-virion inactivated SARS-CoV-2 vaccine (3 μg or 6 μg)
formulated with a toll-like receptor 7/8 agonist molecule (IMDG) adsorbed to alum (Algel). We …

Background We report the clinical efficacy against COVID-19 infection of BBV152, a whole
virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …

Influenza viruses constitute a major health threat and economic burden globally, frequently
exacerbated by preexisting or rapidly emerging resistance to antiviral therapeutics. To …

One of the most preferable characteristics for a COVID-19 vaccine candidate is the ability to
reduce transmission and infection of SARS-CoV-2, in addition to disease prevention. Unlike …

This is a comprehensive report on immunogenicity of COVAXIN ® booster dose against
ancestral and Variants of Concern (VOCs) up to 12 months. It is well known that neutralizing …

Aspergillus is a genus of ubiquitous fungi that are pathologically & therapeutically important.
Aspergillus Secondary Metabolites Database (A2MDB) is a curated compendium of …

Background BBV152 is a whole-virion inactivated SARS-CoV-2 vaccine (3 µg or 6 µg)
formulated with a Toll-like receptor 7/8 agonist molecule adsorbed to alum (Algel-IMDG). Earlier, …

Cajanus platycarpus, an incompatible wild species from the tertiary gene pool of pigeonpea
(C. cajan (L.) Millspaugh), has many desirable characteristics for the improvement of …

ATI-2173 is a novel liver-targeted molecule designed to deliver the 5′-monophosphate of
clevudine for the treatment of chronic hepatitis B infection. Unlike other nucleos(t)ides, the …